BEAM — Beam Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Beam Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	91.8	300	966	1,078	1,190
Net Total Accounts Receivable
Net Total Receivables	—	—	300	0	—
Prepaid Expenses
Total Current Assets	94.5	308	1,273	1,093	1,211
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	43.2	125	187	234	238
Other Long Term Assets
Total Assets	156	452	1,474	1,342	1,460
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.1	102	213	224	206
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	55.2	206	648	608	478
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	101	246	827	733	981
Total Liabilities & Shareholders' Equity	156	452	1,474	1,342	1,460
Total Common Shares Outstanding